Antisense technology in molecular and cellular bioengineering

被引:62
作者
Lee, LK
Roth, CM
机构
[1] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0958-1669(03)00115-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Antisense technology is finding increasing application not only in clinical development, but also for cellular engineering. Several types of antisense methods (e.g. antisense oligonucleotides, antisense RNA and small interfering RNA) can be used to inhibit the expression of a target gene. These antisense methods are being used as part of metabolic engineering strategies to downregulate enzymes controlling undesired pathways with regard to product formation. In addition, they are beginning to be utilized to control cell phenotype in tissue engineering constructs. As improved methods for antisense effects that can be externally regulated emerge, these approaches are likely to find increased application in cellular engineering applications.
引用
收藏
页码:505 / 511
页数:7
相关论文
共 63 条
[1]   Adenovirus-mediated Gαq-protein antisense transfer in neurons replicates Gαq gene knockout strategies [J].
Abogadie, FC ;
Bron, R ;
Marsh, SJ ;
Drew, LJ ;
Haley, JE ;
Buckley, NJ ;
Brown, DA ;
Delmas, P .
NEUROPHARMACOLOGY, 2002, 42 (07) :950-957
[2]   Role for a bidentate ribonuclease in the initiation step of RNA interference [J].
Bernstein, E ;
Caudy, AA ;
Hammond, SM ;
Hannon, GJ .
NATURE, 2001, 409 (6818) :363-366
[3]   Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo [J].
Bertrand, JR ;
Pottier, M ;
Vekris, A ;
Opolon, P ;
Maksimenko, A ;
Malvy, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (04) :1000-1004
[4]   The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript [J].
Bohula, EA ;
Salisbury, AJ ;
Sohail, M ;
Playford, MP ;
Riedemann, J ;
Southern, EM ;
Macaulay, VM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) :15991-15997
[5]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[6]   Genomewide view of gene silencing by small interfering RNAs [J].
Chi, JT ;
Chang, HY ;
Wang, NN ;
Chang, DS ;
Dunphy, N ;
Brown, PO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) :6343-6346
[7]   Antisense DNAs as multisite genomic modulators identified by DNA microarray [J].
Cho, YS ;
Kim, MK ;
Cheadle, C ;
Neary, C ;
Becker, KG ;
Cho-Chung, YS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) :9819-9823
[8]   Novel PDGFβR antisense encapsulated in polymeric nanospheres for the treatment of restenosis [J].
Cohen-Sacks, H ;
Najajreh, Y ;
Tchaikovski, V ;
Gao, G ;
Elazer, V ;
Dahan, R ;
Gati, I ;
Kanaan, M ;
Waltenberger, J ;
Golomb, G .
GENE THERAPY, 2002, 9 (23) :1607-1616
[9]   Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcome [J].
Cordeiro, MF ;
Mead, A ;
Ali, RR ;
Alexander, RA ;
Murray, S ;
Chen, C ;
York-Defalco, C ;
Dean, NM ;
Schultz, GS ;
Khaw, PT .
GENE THERAPY, 2003, 10 (01) :59-71
[10]   Development of an inducible system to assess p94 (CAPN3) function in cultured muscle cells [J].
Dargelos, E ;
Moyen, C ;
Dedieu, S ;
Veschambre, P ;
Poussard, S ;
Vuillier-Devillers, K ;
Brustis, JJ ;
Cottin, P .
JOURNAL OF BIOTECHNOLOGY, 2002, 96 (03) :271-279